MAPT and Alzheimer disease: In line with recent efforts to characterise AD from a biological point of view, the so-called AT(N) framework (i.e., amyloid, tau, neurodegeneration) [6], the relationship between the presence of NPS and detected levels of multiple AD biomarkers has been studied.